Curaleaf Holdings (CURLF) Retained Earnings (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Retained Earnings of $2.3 billion for Q4 2025, up 272.94% year-on-year from $628.9 million in Q4 2024, and up 272.94% on a QoQ basis from -$1.4 billion in Q4 2024.

Curaleaf Holdings (CURLF) Retained Earnings (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Retained Earnings for 7 consecutive years, with $2.3 billion the latest figure, recorded in Q4 2025.

  • Quarterly Retained Earnings rose 272.94% year-over-year to $2.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 billion (up 272.94% YoY) and the FY2025 annual result came in at $2.3 billion, up 272.94% from the prior year.
  • Retained Earnings improved to $2.3 billion in Q4 2025 per CURLF's latest filing, from -$1.4 billion in the prior quarter.
  • Over the last five years, Retained Earnings for CURLF reached as high as $2.3 billion in Q4 2025 and fell as low as -$311.4 billion in Q1 2022.
  • A 5-year average of -$20.9 billion and a median of -$219.1 million in 2021 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2022 — Retained Earnings plunged 146877.19% — and 2025, when it surged 272.94%.
  • Year by year, Retained Earnings stood at -$489.5 million in 2021, then surged by 96.2% to -$18.6 million in 2022, then jumped by 36.14% to -$11.9 million in 2023, then tumbled by 11320.41% to -$1.4 billion in 2024, then jumped by 272.94% to $2.3 billion in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered $2.3 billion, -$1.4 billion, and -$8.1 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.35 Bn
Dec 31, 2024 -1.36 Bn
Sep 30, 2024 -8.05 Mn
Jun 30, 2024 -15.15 Mn
Dec 31, 2023 -11.88 Mn
Sep 30, 2023 -1.08 Bn
Jun 30, 2023 -13.86 Mn
Dec 31, 2022 -18.59 Mn
Sep 30, 2022 -392.06 Mn
Jun 30, 2022 -338.71 Mn
Mar 31, 2022 -311.38 Bn
Dec 31, 2021 -489.46 Mn
Sep 30, 2021 -275.61 Mn
Jun 30, 2021 -219.10 Mn
Mar 31, 2021 -211.86 Mn
Dec 31, 2020 -190.07 Mn
Sep 30, 2020 -159.37 Mn
Dec 31, 2019 -132.91 Mn